Joe C Mathew &Amp; Akshat Kaushal In New Delhi

Stories by Joe C Mathew &Amp; Akshat Kaushal In New Delhi

Real FDI fall not as sharp as magnified: Study

Real FDI fall not as sharp as magnified: Study

Rediff.com   17 Mar 2011

FDI is essentially long-term investments that come with added benefits such as better technology, management and marketing assistance, says the study.

Health Min may ban two drugs soon

Health Min may ban two drugs soon

Rediff.com   16 Mar 2011

The move comes after international studies revealed that Gatifloxacin posed 17 times higher risk of developing serious hyperglycemia than other antibiotics in elderly patients.

Merck aims to be in the top league

Merck aims to be in the top league

Rediff.com   11 Mar 2011

A lot of global products are yet to be launched in the country. In the last eight months, we have launched six products from our global product portfolio.

India-EU FTA: Healthcare norms discussed

India-EU FTA: Healthcare norms discussed

Rediff.com   21 Feb 2011

India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India-EU Free Trade Agreement (FTA) negotiations.

Companies Bill may exclude a cap on subsidiaries

Companies Bill may exclude a cap on subsidiaries

Rediff.com   18 Feb 2011

If implemented, the measure would have choked the availability of funds for real estate firms and infrastructure companies, which typically have several layered subsidiaries.

ICAI seeks info from Sebi, Reliance Infra

ICAI seeks info from Sebi, Reliance Infra

Rediff.com   10 Feb 2011

The letters were meant to assess if there had been any professional misconduct by any auditors of Reliance Infra and Reliance National Resources Ltd that led to the alleged misrepresentation of investments by these companies.

2G scam cases up for further investigation

2G scam cases up for further investigation

Rediff.com   9 Feb 2011

The ministry of corporate affairs - under new minister Murli Deora - has reopened for further investigation the cases of two companies allegedly involved in the unravelling 2G scam. A senior official said that the ministry was currently probing Swan Telecom and Loop Telecom.

Daiichi shifts 6 early drug programmes to India

Daiichi shifts 6 early drug programmes to India

Rediff.com   7 Feb 2011

Daiichi Sankyo, Japan's third-largest drug maker, has transferred six of its early drug discovery programmes in inflammatory and infectious diseases from its Japanese research & development (R&D) facilities to India.

Data exclusivity still key hurdle to India-EU FTA

Data exclusivity still key hurdle to India-EU FTA

Rediff.com   27 Jan 2011

Despite all official assurances, the path towards a free trade agreement (FTA) between India and the European Union (EU) this year remains ambiguous, as both sides are unwilling to relax their stand on the biggest stumbling block - the issue of "data exclusivity".

Exporters seek more time to carry barcodes

Exporters seek more time to carry barcodes

Rediff.com   18 Jan 2011

The domestic drug industry has expressed serious concern over the central government's decision to make it mandatory to carry a barcode on every medicine pack meant for exports from July 1.

Disclose meetings agenda, RBI told

Disclose meetings agenda, RBI told

Rediff.com   27 Dec 2010

RBI has been told to draft a "disclosure policy" by February 2011 to bring about greater transparency in the bank's functioning. The Commission said such a move "will also set the trend for other banks to follow".

Company secys of Swan, Loop pulled up on 2G report

Company secys of Swan, Loop pulled up on 2G report

Rediff.com   13 Dec 2010

The Institute of Company Secretaries of India (ICSI) has pulled up the company secretaries of two telecom companies whose names have been mentioned in the Comptroller and Auditor General's (CAG's) report on the controversial allotment of airwaves. The two officials named in the report are Hari Nair, representing Swan Telecom, and Vidyadhar Chakradeo, the company secretary of Loop Telecom.

Pharma companies line up for clinical trials

Pharma companies line up for clinical trials

Rediff.com   10 Dec 2010

The numbers are the highest ever in the history of domestic drug discovery initiatives triggered by companies such as Dr Reddy's and Ranbaxy over a decade ago.

R&D firms should compensate trial injuries: DCGI

R&D firms should compensate trial injuries: DCGI

Rediff.com   7 Dec 2010

The Drugs Controller General of India, the apex drug regulator, has included a new clause in the trial approval letters, making these firms also accountable for any possible adverse event.

Three controversial drugs may be banned

Three controversial drugs may be banned

Rediff.com   25 Nov 2010

The Central Drugs Standard Control Organisation (CDSCO), the apex drug regulator, may soon ban the production and sale of three medicines in the country. The drugs - cisapride, phenylpropanolamine (PPA) and human placenta extracts - have been controversial medicines for their alleged adverse reactions for several years now.

Price control on 50% of domestic drugs likely

Price control on 50% of domestic drugs likely

Rediff.com   24 Nov 2010

The eight-member expert committee, which is in charge of revising NLEM, plans inclusion of new drugs to the list and also do away with the current practice of including only specific strengths of medicines in NLEM.

Godrej talking to Israeli firms for dairy foray

Godrej talking to Israeli firms for dairy foray

Rediff.com   23 Nov 2010

Godrej Agrovet Ltd, the agri-business arm of leading conglomerate Godrej Ltd, plans to enter the dairy farming business. The company is in talks with at least two leading Israeli dairy farm technology providers.

CWG: Auditors fear bonfire of papers

CWG: Auditors fear bonfire of papers

Rediff.com   22 Nov 2010

The day after the closing ceremony, the Prime Minister's Office had asked the OC to make sure all documents were kept safe.

NPPA finds huge gap in cancer drug prices

NPPA finds huge gap in cancer drug prices

Rediff.com   1 Nov 2010

The first-ever study conducted by the National Pharmaceutical Pricing Authority (NPPA) on cancer medicines has found huge price variations among different brands of same medicines sold in the country.

Govt yet to decide CWG probe panel members

Govt yet to decide CWG probe panel members

Rediff.com   24 Oct 2010

The structure and the exact mandate of the high-level committee set up to probe the alleged financial irregularities related to the conduct of the Commonwealth Games 2010 remain unclear even a week after the setting up of the panel was announced.